Precigen, Inc. (PGEN)
6.60
-0.23
(-3.37%)
USD |
NASDAQ |
Oct 21, 16:00
6.60
0.00 (0.00%)
After-Hours: 20:00
Precigen Net Income (Annual) : -250.64M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -250.64M |
| December 31, 2024 | -126.24M |
| December 31, 2023 | -95.90M |
| December 31, 2022 | -79.78M |
| December 31, 2021 | -110.81M |
| December 31, 2020 | -103.77M |
| December 31, 2019 | -170.33M |
| December 31, 2018 | -414.32M |
| Date | Value |
|---|---|
| December 31, 2017 | -126.82M |
| December 31, 2016 | -190.27M |
| December 31, 2015 | -87.99M |
| December 31, 2014 | -85.62M |
| December 31, 2013 | -59.30M |
| December 31, 2012 | -81.87M |
| December 31, 2011 | -85.28M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Anika Therapeutics, Inc. | -9.979M |
| Aldeyra Therapeutics, Inc. | -33.85M |
| Repligen Corp. | 48.89M |
| AC Immune SA | -84.83M |
| Amgen, Inc. | 7.711B |